ISRG Intuitive Surgical, Inc.
USHealthcareAs of 2026-07-09 11:41
Why ISRG matters now
Intuitive Surgical, Inc. (ISRG) is a US stock in Healthcare. The latest InvestLog snapshot shows $413.92 with -0.28% on the session and $146.60B in market capitalization; recent performance reads 1-month -7.88% and YTD -28.18%.
The latest financial table shown here is Q1 2026, with revenue of $2.77B, net income of $821.5M, and EPS of $2.28. Investors can compare that operating picture with valuation signals such as P/E 56.32 and FCF yield 2.0%.
The latest indexable market news headline is "Here Are Thursday's Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More" from 24/7 Wall Street.
Additional event context on this page matters because analyst consensus is Buy with a median target of $580.00; recent insider activity includes Brosius Mark filing S-Sale; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
56.32
PEG
2.45
P/B
8.26
P/S
13.61
EV/EBITDA
32.88
DCF Value
$130.14
FCF Yield
2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
66.3%
Operating Margin
30.5%
Net Margin
28.2%
ROE
17.0%
ROA
14.8%
ROIC
16.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.77B | $821.5M | $2.28 |
| Q4 2025 | $2.87B | $794.8M | $2.21 |
| FY 2025 | $10.06B | $2.86B | $7.87 |
| Q3 2025 | $2.51B | $704.4M | $1.95 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$597.78
Target (Median)
$580.00
Target Range
$525.00 - $750.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.45
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.